Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises OGI in connection with the sale of Montako to the Finnish Inlook Group
Mandate

Vinge advises OGI in connection with the sale of Montako to the Finnish Inlook Group

February 05, 2019 M&A

Vinge has advised Olsson Groth Invest AB in connection with the sale of the Montako group to Finnish Inlook Group

The Montako group is one of Sweden’s market leading within false ceilings, activity adapted acoustics and specially assembly products and consists of Montagegruppen I Malmö AB as well as TJ Akustiktak AB, Undertakman I Blekings AB and AB Smålands Undertak with a total turnover of approximately SEK 120 million. Inlook Group is the market leader in Finland within interior construction, false ceilings and specially assembled products and also conducts operations in Estonia and Lithuania. Inlook Group has a turnover of approximately SEK 800 million and has 450 employees.

Vinge’s team consisted of Kristian Ford and Anna Edström (real estate related issues).
 

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

 Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

 Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026